• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    PTC Therapeutics, Inc. - Common Stock (NQ:PTCT)

    64.13 -0.65 (-1.00%)
    Delayed Quote Updated: 4:00 PM EDT, Oct 1, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,197,752
    Open 64.70
    Bid (Size) 58.92 (100)
    Ask (Size) 75.00 (100)
    Prev. Close 64.78
    Today's Range 63.40 - 65.56
    52wk Range 60.80 - 90.87
    Shares Outstanding 81,474,366
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    PTC Therapeutics Targets Fabry Gene Therapy in $111M Bankruptcy Auction Deal ↗
    PTC Therapeutics (NASDAQ:PTCT) plans to acquire the ST-920 Fabry disease gene therapy asset through a competitive bankruptcy auction, positioning the company to add a potential one-time treatment to... 
    Via MarketBeat
    Topics Bankruptcy
    News headline image
    PTC Therapeutics Q2 Earnings Call Highlights ↗
    PTC Therapeutics (NASDAQ:PTCT) reported second-quarter total revenue of $361 million and raised its 2026 outlook, citing continued growth from its Sephience launch and greater durability than expected... 
    Via MarketBeat
    Topics Earnings

    Performance

    YTD
    -16.4%
    -16.4%
    1 Month
    -9.1%
    -9.1%
    3 Month
    -23.0%
    -23.0%
    6 Month
    -5.4%
    -5.4%
    1 Year
    +3.4%
    +3.4%

    More News

    Read More
    PTC Therapeutics (NASDAQ:PTCT) Soars on Q2 Earnings Beat and Raised Guidance ↗
    Via Chartmill
    Topics Earnings
    News headline image
    What This PTC Therapeutics Insider Sale Means as Product Revenue Hit $226 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    PTC THERAPEUTICS INC (NASDAQ:PTCT) Scores Perfect 10/10 For Technical Breakout Setup ↗
    Via Chartmill
    PTC Therapeutics Inc (NASDAQ:PTCT) Delivers Q1 Earnings Beat and Raises 2026 Guidance ↗
    Via Chartmill
    Topics Earnings
    PTC Therapeutics Inc (NASDAQ:PTCT) Stock Slides After Q4 Earnings Miss ↗
    Via Chartmill
    PTC Therapeutics Inc (NASDAQ:PTCT) Presents a Compelling Growth and Technical Setup ↗
    Via Chartmill
    News headline image
    Why This Fund Made a $189 Million Bet on Erasca as Shares Skyrocket 800% ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Tango Therapeutics Stock Is Up 840%, and This Fund Just Disclosed Buying $164 Million More ↗
    Via The Motley Fool
    News headline image
    PTC Therapeutics Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    PTC Therapeutics Inc (NASDAQ:PTCT): A GARP Stock with Strong Growth and Moderate Valuation ↗
    Via Chartmill
    PTC Therapeutics Inc (NASDAQ:PTCT) Combines High-Growth Momentum with Bullish Technical Setup ↗
    Via Chartmill
    PTC Therapeutics Inc (NASDAQ:PTCT) Emerges as a High-Growth Momentum Breakout Candidate ↗
    Via Chartmill
    PTC Therapeutics Inc (NASDAQ:PTCT) Combines Strong Growth with a Bullish Technical Setup ↗
    Via Chartmill
    News headline image
    PTCT Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    PTC Therapeutics Inc (NASDAQ:PTCT): A Prime Candidate for Affordable Growth Investing ↗
    Via Chartmill
    News headline image
    This Specialized Heart Monitor Maker Just Caught the Eye of a Major Healthcare Fund ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Investment Manager Bets Big on PTCT Stock, Adds 41,000 Shares, According to Recent SEC Filing ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Investment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC Filing ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    PTC THERAPEUTICS INC (NASDAQ:PTCT) Shows High-Growth Momentum and Bullish Technical Setup ↗
    Via Chartmill
    News headline image
    PTC Therapeutics Inc (NASDAQ:PTCT) Presents a Compelling Growth and Technical Setup ↗
    Via Chartmill

    Frequently Asked Questions

    Is PTC Therapeutics, Inc. - Common Stock publicly traded?
    Yes, PTC Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does PTC Therapeutics, Inc. - Common Stock trade on?
    PTC Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for PTC Therapeutics, Inc. - Common Stock?
    The ticker symbol for PTC Therapeutics, Inc. - Common Stock is PTCT on the Nasdaq Stock Market
    What is the current price of PTC Therapeutics, Inc. - Common Stock?
    The current price of PTC Therapeutics, Inc. - Common Stock is 64.13
    When was PTC Therapeutics, Inc. - Common Stock last traded?
    The last trade of PTC Therapeutics, Inc. - Common Stock was at 10/01/26 04:00 PM ET
    What is the market capitalization of PTC Therapeutics, Inc. - Common Stock?
    The market capitalization of PTC Therapeutics, Inc. - Common Stock is 5.22B
    How many shares of PTC Therapeutics, Inc. - Common Stock are outstanding?
    PTC Therapeutics, Inc. - Common Stock has 5B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.